Javascript must be enabled to continue!
Toward a comprehensive neurobiology of IGF‐I
View through CrossRef
AbstractInsulin‐like growth factor I (IGF‐I) belongs to an ancient family of hormones already present in early invertebrates. The insulin family is well characterized in mammals, although new members have been described recently. Since its characterization over 50 years ago, IGF‐I has been considered a peptide mostly involved in the control of body growth and tissue remodeling. Currently, its most prominent recognized role is as a quasi‐universal cytoprotectant. This role connects IGF‐I with regulation of lifespan and with cancer, two areas of very active research in relation to this peptide. In the brain, IGF‐I was formerly considered a neurotrophic factor involved in brain growth, as many other neurotrophic factors. Other aspects of the neurobiology of IGF‐I are gradually emerging and suggest that this growth factor has a prominent role in brain function as a whole. During development IGF‐I is abundantly expressed in many areas, whereas once the brain is formed its expression is restricted to a few regions and in very low quantities. However, the adult brain appears to have an external input from serum IGF‐I, where this anabolic peptide is abundant. Thus, serum IGF‐I has been proven to be an important modulator of brain activity, including higher functions such as cognition. Many of these functions can be ascribed to its tissue‐remodeling activity as IGF‐I modulates adult neurogenesis and angiogenesis. Other activities are cytoprotective; indeed, IGF‐I can be considered a key neuroprotective peptide. Still others pertain to the functional characteristics of brain cells, such as cell excitability. Through modulation of membrane channels and neurotransmission, IGF‐I impinges directly on neuronal plasticity, the cellular substrate of cognition. However, to fully understand the role of IGF‐I in the brain, we have to sum the actions of locally produced IGF‐I to those of serum IGF‐I, and this is still pending. Thus, an integrated view of the role played by IGF‐I in the brain is not yet possible. An operational approach to overcome this limitation would be to consider IGF‐I as a signal coupling environmental influences on body metabolism with brain function. Or in a more colloquial way, we may say that IGF‐I links body “fitness” with brain fitness, providing a mechanism to the roman saying “mens sana in corpore sano.” © 2010 Wiley Periodicals, Inc. Develop Neurobiol 2010
Title: Toward a comprehensive neurobiology of IGF‐I
Description:
AbstractInsulin‐like growth factor I (IGF‐I) belongs to an ancient family of hormones already present in early invertebrates.
The insulin family is well characterized in mammals, although new members have been described recently.
Since its characterization over 50 years ago, IGF‐I has been considered a peptide mostly involved in the control of body growth and tissue remodeling.
Currently, its most prominent recognized role is as a quasi‐universal cytoprotectant.
This role connects IGF‐I with regulation of lifespan and with cancer, two areas of very active research in relation to this peptide.
In the brain, IGF‐I was formerly considered a neurotrophic factor involved in brain growth, as many other neurotrophic factors.
Other aspects of the neurobiology of IGF‐I are gradually emerging and suggest that this growth factor has a prominent role in brain function as a whole.
During development IGF‐I is abundantly expressed in many areas, whereas once the brain is formed its expression is restricted to a few regions and in very low quantities.
However, the adult brain appears to have an external input from serum IGF‐I, where this anabolic peptide is abundant.
Thus, serum IGF‐I has been proven to be an important modulator of brain activity, including higher functions such as cognition.
Many of these functions can be ascribed to its tissue‐remodeling activity as IGF‐I modulates adult neurogenesis and angiogenesis.
Other activities are cytoprotective; indeed, IGF‐I can be considered a key neuroprotective peptide.
Still others pertain to the functional characteristics of brain cells, such as cell excitability.
Through modulation of membrane channels and neurotransmission, IGF‐I impinges directly on neuronal plasticity, the cellular substrate of cognition.
However, to fully understand the role of IGF‐I in the brain, we have to sum the actions of locally produced IGF‐I to those of serum IGF‐I, and this is still pending.
Thus, an integrated view of the role played by IGF‐I in the brain is not yet possible.
An operational approach to overcome this limitation would be to consider IGF‐I as a signal coupling environmental influences on body metabolism with brain function.
Or in a more colloquial way, we may say that IGF‐I links body “fitness” with brain fitness, providing a mechanism to the roman saying “mens sana in corpore sano.
” © 2010 Wiley Periodicals, Inc.
Develop Neurobiol 2010.
Related Results
The mechanism of maturation of insulin-like growth factor-1
The mechanism of maturation of insulin-like growth factor-1
This study, to elucidate the role of des(1-3)IGF-I in the maturation of IGF-I,used two strategies. The first was to detect the presence of enzymes in tissues, which would act on IG...
The basic route of nuclear‐targeted transport of IGF‐1/IGF‐1R and potential biological functions in intestinal epithelial cells
The basic route of nuclear‐targeted transport of IGF‐1/IGF‐1R and potential biological functions in intestinal epithelial cells
AbstractObjectivesInsulin‐like growth factor (IGF‐1) plays an important role in many biological processes in the intestinal tract. However, the cellular behaviour and characteristi...
Estrogen and IGF-I Independently Down-Regulate Critical Repressors of Breast Cancer Growth.
Estrogen and IGF-I Independently Down-Regulate Critical Repressors of Breast Cancer Growth.
Abstract
Background: Estrogen receptor and insulin-like growth factor (IGF) signaling pathways are important for both normal mammary gland development and breast can...
7780 Silver - Russell Syndrome and Free Insulin-like Growth Factor-1 Measurements
7780 Silver - Russell Syndrome and Free Insulin-like Growth Factor-1 Measurements
Abstract
Disclosure: R.D. Oude Engberink: None. V. van den Bogert: None. L. IJsselstijn: None. S.A. van den Berg: None. D.C. van der Kaay: None.
Intro...
9282 Silver - Russell Syndrome and Free Insulin-like Growth Factor-1 Measurements
9282 Silver - Russell Syndrome and Free Insulin-like Growth Factor-1 Measurements
Abstract
Disclosure: R.D. Oude Engberink: None. V. van den Bogert: None. L. IJsselstijn: None. S.A. van den Berg: None. D.C. van der Kaay: None.
Intro...
BCR-ABL Activates IGF-1 Expression and Signaling in Chronic Myelogenous Leukemia Blast Crisis Cell Lines.
BCR-ABL Activates IGF-1 Expression and Signaling in Chronic Myelogenous Leukemia Blast Crisis Cell Lines.
Abstract
CML blast crisis is characterized by the continued presence of the Philadelphia chromosome, which expresses the P210 BCR-ABL fusion protein, and the acquisi...
BCR-ABL Induces Autocrine IGF-1 Signaling.
BCR-ABL Induces Autocrine IGF-1 Signaling.
Abstract
BCR-ABL is responsible for the initial phase of chronic myelogenous leukemia (CML), which is effectively treated by the BCR-ABL tyrosine kinase inhibitor im...
Changes in IGFs in cardiac tissue following myocardial infarction
Changes in IGFs in cardiac tissue following myocardial infarction
We have studied changes in the IGF axis in an ovine model of myocardial infarction (MI), in order to determine the relationship between time-based changes in post-infarct myocardiu...

